Abstract
Objective: To determine whether tight control of blood pressure with either a β blocker or an angiotensin converting enzyme inhibitor has a specific advantage or disadvantage in preventing the macrovascular and microvascular complications of type 2 diabetes.
Keywords
MeSH Terms
Related Publications
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
Objective: To determine whether tight control of blood pressure prevents macrovascular and microvascular complications in patients with type 2 diabetes.
UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance.
The UK Prospective Diabetes Study (UKPDS) is a multi-centre, prospective, randomised, intervention trial of 5100 newly-diagnosed patients with Type 2 (non-insulin-dependent) dia...
Impact of the UKPDS—an overview
Abstract The UK Prospective Diabetes Study (UKPDS) is a group of clinical trials, epidemiological analyses and health‐modelling studies with an influence which can be assessed a...
Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes
The angiotensin-II-receptor blocker irbesartan is effective in protecting against the progression of nephropathy due to type 2 diabetes. This protection is independent of the re...
Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study
In patients with type 2 diabetes the risk of diabetic complications was strongly associated with raised blood pressure. Any reduction in blood pressure is likely to reduce the r...
Publication Info
- Year
- 1998
- Type
- article
- Volume
- 317
- Issue
- 7160
- Pages
- 713-720
- Citations
- 1387
- Access
- Closed
External Links
Social Impact
Social media, news, blog, policy document mentions
Citation Metrics
Cite This
Identifiers
- DOI
- 10.1136/bmj.317.7160.713
- PMID
- 9732338
- PMCID
- PMC28660